CytoAgents
Phase 1CytoAgents is developing innovative pharmaceutical products for the treatment of symptoms associated with Cytokine Release Syndrome (CRS) and ICANS.
Founded
2016
Focus
Small Molecules
About
CytoAgents is developing innovative pharmaceutical products for the treatment of symptoms associated with Cytokine Release Syndrome (CRS) and ICANS.
Company Info
TypePrivate
Founded2016
LocationSan Diego, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile